Results 181 to 190 of about 10,988 (206)

Gene Therapy and Virotherapy of Gliomas

2018
Despite many recent advances in the management of gliomas, such as aggressive surgical resection, chemoradiotherapy, antiangiogenic therapy, and molecular targeted therapy, the survival of patients with high-grade neoplasms remains dismal. Gene therapy and oncolytic virotherapy have emerged as highly promising strategies for treatment of malignant ...
Julius W, Kim, Alan L, Chang, J Robert, Kane, Jacob S, Young, Jian, Qiao, Maciej S, Lesniak   +5 more
openaire   +2 more sources

Mathematical Modeling of Oncolytic Virotherapy

2019
Mathematical modeling in biology has a long history as it allows the analysis and simulation of complex dynamic biological systems at little cost. A mathematical model trained on experimental or clinical data can be used to generate and evaluate hypotheses, to ask "what if" questions, and to perform in silico experiments to guide future experimentation
Johannes P W, Heidbuechel, Daniel, Abate-Daga, Christine E, Engeland, Heiko, Enderling   +3 more
openaire   +2 more sources

Virotherapy

2023
Sathiamoorthi Thangavelu, Saikishore Ramanthan, Palanivel Velmurugan, Ranjithkumar Dhandapani   +3 more
openaire   +1 more source

Virotherapy in cancer.

Iranian journal of cancer prevention, 2014
New cancer therapies with novel mechanisms and functions are needed to treatpatients with different cancers. Virotherapy is a good scenario for such treatment. The advantages of virotherapy include the potential lack of cross resistance with standard therapies and the ability to cause tumor destruction by numerous mechanisms.
openaire   +1 more source

Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective

Cancer Cell, 2021
Christian Beisel, Emmanuella Guenova, Egle Ramelyte   +2 more
exaly  

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma

Pharmaceuticals, 2023
Uğur Sener, Richard Vile, Mason Webb
exaly  

Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis

Vaccines, 2021
Toos Daemen, Chammas R, Darshak Bhatt
exaly  

Virotherapy

2008
Zeng B. Zhu, Bruce F. Smith, Gene P. Siegal, David T. Curiel   +3 more
openaire   +1 more source

Oncolytic Virotherapy with Myxoma Virus

Journal of Clinical Medicine, 2020
Diana Thomas, Grant McFadden, Masmudur Mohammed Rahman   +2 more
exaly  

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy

Pharmaceutics, 2021
Arianna Calistri, Jennifer Altomonte, Alberto Reale   +2 more
exaly